Sign Up Today and Learn More About Sagimet Biosciences Stock
Invest in or calculate the value of your shares in Sagimet Biosciences or other pre-IPO companies through EquityZen's platform.
Sagimet Biosciences Stock
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
About Sagimet Biosciences Stock
Founded
2007
Headquarters
San Mateo, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a pipeline of proprietary FASN inhibitors.
Sagimet Biosciences Management
Leadership team at Sagimet Biosciences
Member of the Board of Directors
Beth Seidenberg
CEO
George Kemble
Join now and verify your accreditation status to gain access to:
- Sagimet Biosciences current valuation
- Sagimet Biosciences stock price
- Available deals in Sagimet Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Sagimet Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Sagimet Biosciences through EquityZen funds. These investments are made available by existing Sagimet Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Sagimet Biosciences stock?
Shareholders can sell their Sagimet Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
